Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01312376 |
Recruitment Status :
Terminated
First Posted : March 10, 2011
Last Update Posted : April 24, 2020
|
Sponsor:
Abramson Cancer Center at Penn Medicine
Information provided by (Responsible Party):
Abramson Cancer Center at Penn Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | October 2015 |
Actual Study Completion Date : | January 2019 |